1. In relation to D-Cubed Ltd -a. Were D-Cubed Ltd required to provide Alpha with disclosure under Chapter 6 D of

Flinders Partners Consultants and Corporate Advisers CLIENT INSTRUCTIONS A number of issues are brought to our attention: In July 2019. Dillion received information about a new company "D-Cubed Ltd" — an Australian company with its registered office located in Sydney. Dlliion read an article in a scientific journal last year about SD printing silicone heart valves for surgeries. Wading; unlike existing products. 30 printed valves are custom fit to patients. are longer lasting. do not require immunosuppression drugs. and potentially less expensive. It sounded like a great idea and Dillion's industry research established that D-Cubed Ltd were looking to manufacture 3D printing silicone machines for Australian hospitals. Carol and Dillon met with the company's executives later that month and were provided with a prospectus which included the following statement: "Funds raised will be principally utilised to purchase land and buildings in Tullarnarine, Victoria, and capital equipment required to manufacture 3D printing machines." In August 2019. Aipha acquired 500.000 ordinary shares D~Cubed Ltd at $1 per share. No other investors made investments in D~Cubed Ltd. In February 2020. it is now revealed that D-Cubed Ltd used funds to purchase land in Altona not Tullamanne. Further this land was for the company's head office and could not accommodate an industrial factory required to manufacture the 3D printing machines. Leaked documents dated April 2019 reveal that D-Cubed had always pianned to engage a third party contractor overseas to manufacture the machines and have them shipped to Australia. Carol has personally complained to senior management and they threatened to cancel Alpha's shares. In August 2020. Carol has offers from an additional 10 individual sophisticated investors to invest at least $300.000 in Alpha in exchange for ordinary shares. Joe tells Carol that he does not think Alpha is able to issue shares to all 10 prospective investors and recommends listing on the Australian Stock Exchange. In September 2020. Alpha received notice that a company that they are invested in - Wearable Diagnostics Pty Ltd — is insolvent and the directors have put the company into voluntary administration. Alpha purchased $2 million worth of shares in the company in 2018. Carol and Dillon still believe in its fundamental business proposition and think that the problem is with incompetent management and operating inefficiencies. Joe proposes that it might be possible for Alpha to save or otherwise take over the Wearable Diagnostics' business.